Cardinal Health, Inc. (NYSE:CAH) Holdings Boosted by Natixis

Natixis boosted its holdings in Cardinal Health, Inc. (NYSE:CAH) by 147.1% during the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 38,130 shares of the company’s stock after acquiring an additional 22,700 shares during the period. Natixis’ holdings in Cardinal Health were worth $4,267,000 at the end of the most recent quarter.

Several other large investors also recently made changes to their positions in the company. Aaron Wealth Advisors LLC boosted its stake in Cardinal Health by 1.2% in the 4th quarter. Aaron Wealth Advisors LLC now owns 8,369 shares of the company’s stock worth $844,000 after purchasing an additional 97 shares during the period. Schechter Investment Advisors LLC boosted its stake in Cardinal Health by 4.1% in the 4th quarter. Schechter Investment Advisors LLC now owns 2,480 shares of the company’s stock worth $250,000 after purchasing an additional 98 shares during the period. J. W. Coons Advisors LLC boosted its stake in Cardinal Health by 0.6% in the 4th quarter. J. W. Coons Advisors LLC now owns 16,680 shares of the company’s stock worth $1,681,000 after purchasing an additional 100 shares during the period. Edmonds Duncan Registered Investment Advisors LLC boosted its stake in Cardinal Health by 5.0% in the 1st quarter. Edmonds Duncan Registered Investment Advisors LLC now owns 2,090 shares of the company’s stock worth $234,000 after purchasing an additional 100 shares during the period. Finally, Checchi Capital Advisers LLC boosted its stake in Cardinal Health by 3.2% in the 1st quarter. Checchi Capital Advisers LLC now owns 3,758 shares of the company’s stock worth $421,000 after purchasing an additional 115 shares during the period. Institutional investors and hedge funds own 87.17% of the company’s stock.

Cardinal Health Price Performance

Shares of CAH opened at $97.42 on Friday. The company has a market capitalization of $23.73 billion, a PE ratio of 43.07, a price-to-earnings-growth ratio of 1.07 and a beta of 0.61. Cardinal Health, Inc. has a one year low of $85.11 and a one year high of $116.04. The company’s fifty day moving average price is $98.03 and its 200 day moving average price is $103.64.

Cardinal Health (NYSE:CAH) last announced its earnings results on Thursday, May 2nd. The company reported $2.08 EPS for the quarter, topping the consensus estimate of $1.95 by $0.13. The firm had revenue of $54.90 billion for the quarter, compared to the consensus estimate of $56.05 billion. Cardinal Health had a net margin of 0.25% and a negative return on equity of 54.74%. The business’s quarterly revenue was up 8.7% on a year-over-year basis. During the same quarter last year, the firm posted $1.74 EPS. Analysts anticipate that Cardinal Health, Inc. will post 7.35 earnings per share for the current year.

Cardinal Health Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Monday, July 15th. Stockholders of record on Monday, July 1st were issued a dividend of $0.5056 per share. This is an increase from Cardinal Health’s previous quarterly dividend of $0.50. The ex-dividend date of this dividend was Monday, July 1st. This represents a $2.02 annualized dividend and a dividend yield of 2.08%. Cardinal Health’s payout ratio is presently 89.78%.

Analysts Set New Price Targets

A number of equities analysts recently commented on the stock. Citigroup decreased their price objective on shares of Cardinal Health from $115.00 to $107.00 and set a “neutral” rating for the company in a research note on Friday, July 19th. Argus decreased their price objective on shares of Cardinal Health from $120.00 to $115.00 and set a “buy” rating for the company in a research note on Wednesday, May 15th. StockNews.com raised shares of Cardinal Health from a “buy” rating to a “strong-buy” rating in a research note on Monday. Robert W. Baird lifted their target price on shares of Cardinal Health from $129.00 to $130.00 and gave the company an “outperform” rating in a research note on Tuesday, July 9th. Finally, Wells Fargo & Company decreased their target price on shares of Cardinal Health from $96.00 to $94.00 and set an “underweight” rating for the company in a research note on Monday, April 29th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating, seven have given a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, Cardinal Health currently has a consensus rating of “Moderate Buy” and an average price target of $109.67.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.